EnteroBiotix Completes £27m Financing Round to Advance Clinical Trials tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Allogeneic cell therapy hasn’t caught up to autologous cell therapy yet, and the disappointing data so far has soured the entire allogeneic field for at least one venture capitalist. The cell therapy debate was one of the topics covered during a panel discussion at the Biopharm America conference.
Kineticos Ventures has been busy investing as well. In late May, eXmoor pharma, a UK cell and gene therapy manufacturer partner closed on a $35 million Series A round of funding from Kineticos and one other.
Kincell Bio, a new company formed to develop and manufacture cell therapies for biotechnology companies, may be based in Florida, but it has North Carolina fingerprints all over it. And also management has lots of new cash.